Litigation Status
Where this docket stands today
Philips CPAP MDL (MDL 3014) in the Western District of Pennsylvania remains active. Philips issued a massive recall in June 2021 covering millions of CPAP, BiPAP, and mechanical ventilator devices after identifying that the polyester-based polyurethane (PE-PUR) foam in the devices could degrade and release potentially toxic particles and gases. Settlement negotiations have been ongoing. Personal injury claims for cancer and respiratory harm continue to be filed as new diagnoses emerge.
Docket-Specific Pre-Screen
What we confirm before every CPAP lead is delivered
- Philips CPAP, BiPAP, or mechanical ventilator use confirmed — recalled model.
- Device model identified where possible — DreamStation, System One, Trilogy, or other recalled product.
- Recall registration status documented — registered with Philips or unregistered.
- Cancer diagnosis or respiratory injury confirmed — lung cancer, kidney cancer, reactive airway disease, or other qualifying conditions.
- Device in use during the recall period or prior to the recall announcement.
- Treating physician or oncologist referenced at pre-screen.
- Not part of an existing resolved settlement of the Philips recall.
- Not currently represented — confirmed before the lead leaves our system.
The Market
The CPAP market
Philips Respironics issued a recall in June 2021 covering millions of CPAP, BiPAP, and mechanical ventilator devices after identifying that the polyester-based polyurethane (PE-PUR) sound-abatement foam could degrade into particles and off-gas potentially toxic chemicals. The recalled devices were used for years, often nightly, by patients with sleep apnea and respiratory conditions. Personal injury plaintiffs allege the degradation caused cancers and respiratory harm.
MDL 3014 is consolidated in the Western District of Pennsylvania. The litigation has moved through bellwether selection and is in active pre-trial. Settlement discussions have been ongoing but new personal injury claims continue to be filed as claimants receive new cancer or respiratory diagnoses they associate with device use.
Why CPAP leads need specialist qualification: the device must be a recalled Philips model — generic CPAP machines or other manufacturers are not part of this docket. And the qualifying diagnosis must be one of the cancer or respiratory injury types associated with the PE-PUR foam exposure theory.
Docket Pipeline
How Philips CPAP leads are qualified
Targeted Acquisition
Only people who matched your exact criteria submitted a form.
Form Pre-Screen
SOL, liability, insurance, and intent — all confirmed before delivery.
OTP Phone Verification
The number is real. We proved it before you see it.
Exclusive Delivery
Your CRM. One firm. In under 15 seconds.
Pricing is per qualified lead — never a retainer, never a setup fee, never a monthly commitment. Calculate your all-in cost per signed retainer before you book the call.
Delivery Standards
How every lead arrives and what stands behind it
Every lead passes through four verification steps before delivery. Targeted acquisition drives intake traffic only from people who match your stated criteria. The form pre-screen documents SOL, liability, injury severity, and representation status. OTP phone verification confirms the number is real, active, and in possession of the claimant — not Google Voice, not a disconnected line, not a wrong number. Exclusive delivery places the lead into your CRM inside 15 seconds, locked to your firm ID with a permanent delivery timestamp.
Exclusivity is contractual, not verbal. Your client agreement contains a binding exclusivity term — every lead is sold to exactly one firm and there is no operational path for us to re-deliver it. TrustedForm certificates and Jornaya lead IDs travel with every lead as an independent consent audit trail, timestamped outside our own delivery system. The 48-hour credit exchange is written into your agreement as a contract term, not a return policy: expired SOL at delivery, liability that clearly does not hold based on pre-screen facts, case type mismatch, or represented-at-delivery all qualify without additional documentation. Your intake team’s assessment is sufficient.
Coverage runs in 38 states. Pricing is per qualified lead — no retainer, no setup fee, no monthly commitment. Volume can be paused or reduced with 30 days notice without penalty. Auto-connect puts your intake team on the phone with the claimant within 60 seconds of delivery, which is the single largest lever on contact-to-signed-retainer conversion in every vendor benchmark we have run. Firms routinely report 18–23% close rates on identical leads simply by moving first-call contact from 5 minutes to 60 seconds.
Read the full pipeline breakdown for operational detail on each verification step, or run your numbers with the cost-per-retainer calculator before booking a call.
Frequently Asked Questions
- Yes. MDL 3014 remains active in the Western District of Pennsylvania. Settlement discussions are ongoing but personal injury claims continue to be filed as new diagnoses emerge. The docket is in a mature but active phase.
Related dockets
The Arrangement
No retainer. No setup fee. No monthly commitment.
Start receiving verified leads in 5–7 days. One firm per case. Every lead OTP-verified. Credit exchange written into your client agreement.